SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-007600
Filing Date
2019-08-08
Accepted
2019-08-08 09:01:28
Documents
83
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrsn-20190630x10q.htm 10-Q 1755441
2 EX-10.1 mrsn-20190630ex1012869b3.htm EX-10.1 451117
3 EX-10.2 mrsn-20190630ex102e61657.htm EX-10.2 35844
4 EX-31.1 mrsn-20190630ex3111ee98a.htm EX-31.1 11930
5 EX-31.2 mrsn-20190630ex312f826d7.htm EX-31.2 13648
6 EX-32.1 mrsn-20190630ex321dc4a3a.htm EX-32.1 16041
  Complete submission text file 0001558370-19-007600.txt   7870465

Data Files

Seq Description Document Type Size
7 EX-101.INS mrsn-20190630.xml EX-101.INS 1679985
8 EX-101.SCH mrsn-20190630.xsd EX-101.SCH 53622
9 EX-101.CAL mrsn-20190630_cal.xml EX-101.CAL 57987
10 EX-101.DEF mrsn-20190630_def.xml EX-101.DEF 167431
11 EX-101.LAB mrsn-20190630_lab.xml EX-101.LAB 479687
12 EX-101.PRE mrsn-20190630_pre.xml EX-101.PRE 364947
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38129 | Film No.: 191007688
SIC: 2834 Pharmaceutical Preparations